MoneyWorks4Me

Lupin reports consolidated net loss of Rs 783.54 crore in Q4

15 May 2018 Evaluate

Lupin has reported results for the fourth quarter and year ended March 31, 2018.

The company has reported a fall of 46.73% in its net profit at Rs 292.46 crore for the quarter ended March 31, 2018, as compared to Rs 549.05 crore for the same quarter in the previous year. Total income of the company decreased by 14.66% at Rs 2,530.83 crore for the quarter under review as compared Rs 2,965.71 crore for the quarter ended March 31, 2017.

On consolidated basis, the company has reported net loss of Rs 783.54 crore for the quarter ended March 31, 2018 as compared to a net profit of Rs 380.21 crore for the corresponding quarter in the FY17. Total income of the company decreased marginally by 2.79% at Rs 4,178.75 crore for quarter under review as compared to Rs 4,298.64 crore for the same quarter ended previous year. 

For the year ended March 31, 2018, the company has posted a fall of 57.19% in its net profit at Rs 1,344.66 crore as compared to Rs 3,141.33 crore for the same period in the previous year. Total income of the company decreased 20.42% at Rs 10,219.30 crore for year under review as compared to Rs 12,841.62 crore for the period ended March 31, 2017.

For the year ended March 31, 2018, on the consolidated basis, the company has posted fall of 90.18% in its net profit at Rs 251.26 crore as compared to Rs 2,557.46 crore for the same period in the previous year. Total income of company has decreased by 9.35% at Rs 15,954.50 crore for year under review as compared to Rs 17,600.84 crore for the period ended March 31, 2017.


Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..